Floxin otic
Company: Daiichi Pharmaceutical
Approval Status: Approved December 1997
Treatment for: otitis media (ear infections)
Areas: Otolaryngology; Pediatrics/Neonatology
Possible similar drugs: Floxin Tablets
| General Information | Side Effects |
General Information
Floxin otic (ofloxacin otic solution) has been approved for the treatment of various forms of otitis media in pediatric and adult patient populations. Labeling directs otitis externa pediatric patients, one to 12 years old, to take five drops instilled into the affected ear twice daily for ten days. Patients 12 years and older should take ten drops twice daily for ten days.
Side Effects
Side effects reported during clinical trials included pruritis, application site reaction, dizziness, earache, taste perversion, and vertigo.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
